4 In concentration-response relationships of BZR partial agonists, the threshold concentrations, KD values and maximal augmentation ratio of the GABA response were similar in all CTX, CPJ and SVH neurones. Also, in all preparations, the threshold concentration and KD values of diazepam action were 10 fold less than those induced by partial agonists. 5 All BZR agonists shifted the concentration-response relationship for GABA to the left without changing the maximum current amplitude, indicating that activation of both BZ1 and BZ2 increase the affinity of the GABAA receptor for GABA. 6 The results are important in clarifying the mechanism of anxiety and might explain the anxioselectivity of BZR partial agonists.
Introduction
Benzodiazepines (BZPs) have been widely used as clinical anxiolytics. Although these drugs have many advantages, they also have a number of undesirable adverse reactions such as muscle relaxation, dizziness, hypnogenesis and reduction of vigilance, amnesia induction and dependency liability. Therefore, recent research has emphasized the search for novel anxiolytics in which these adverse reactions are absent.
The benzodiazepine receptor (BZR) interacts functionally and structurally with GABAA and barbiturate receptors which are coupled with Cl-channel (Olsen 1981) , and BZPs facilitate the GABA-induced Cl-current (Icl) (Study & Barker, 1981; Hattori et al., 1986; Yakushiji et al., 1989a) . The search for novel anxiolytics is focusing on partial BZR agonists. They have anxiolytic and anticonvulsant properties, but do not induce ataxia and sedation Morimoto et al., 1990) . Y-23684 (see Figure 1) , is one such drug. Functional differences such as anxioselectivity, between partial and full agonists may be explained by the following: (1) their intrinsic efficacies and (2) the differences between receptor density in various CNS regions (Haefely, 1987) .
On the other hand, two subtypes of BZR, type I (BZ,) and II (BZ2), have been classified pharmacologically. The former is sensitive to CL218,872, one of the partial agonists, and the latter is less sensitive to the drug (Squires et al., 1979) . A recent gene cloning technique has also revealed the structural variants of GABAA/BZP receptor subtypes. The GABAA receptor-Cl-channel complex consists of some subunits such as a, P, y, 6, and each subunit has some isoforms, , B, 4, Y, 3 (Olsen & Tobin, 1990 ; Burt & Kamatchi, ' Author for correspondence at: Department of Neurophysiology, Tohoku University School of Medicine, Sendai 980, Japan. 1991). A recombinant GABAA receptor-Cl-channel complex composed of ocl, PI, and '2 subunits has BZ1-like properties, whereas one from X2,3 or 5, PI, and '2 subunits has BZ2-like properties. The existence of BZR subtypes complicates the situation of the partial agonists, because of the necessity to consider both affinity and intrinsic efficacy of the ligand for a single receptor subtype. Since we know that the recombinant receptors do not always reflect the physiological condition, it is important to clarify the functional difference in receptor subtypes in mammalian CNS neurones to elucidate the significance of 'partial agonistic effects' on anxioselectivity.
The expression of mRNA encoding the oEl subunit and that encoding a2 and M3 subunits are predominant in cerebellar Purkinje (CPJ) and spinal ventral horn (SVH) neurones, respectively (Young et al., 1981; MacLennan et al., 1991; Persohn et al., 1991; Wisden et al., 1991; Doble & Martin, 1992) . Therefore, in the present experiment, we first compared the potency of the full agonist (diazepam) with those of partial agonists (Y-23684 and CL218,872) on the enhancement of GABA-induced Ic, in both CPJ and SVH neurones acutely dissociated from the rat brain and spinal cord, and then studied the properties of all three in cerebral cortex (CTX) neurones.
Methods
Preparation CTX, CPJ and SVH neurones were acutely dissociated from 13 to 17, 28 to 35, and 7 to 14 day-old Wistar rats, respectively. Transverse slices (400 lm) of the cortex, cerebellum and spinal cord were cut with a microslicer (Dosaka, DTK-1000) (Kaneda et al., 1990; Murase et al., 1990; Shirasaki et al., 1991) . The slices were pre-incubated in a standard external solution well saturated with pure°2 at room temperature for 50min. Thereafter, slices were treated with 0.05% pronase, followed by 0.05% thermolysin at 31°C, each for 20 to 40min. In some experiments, the spinal slices were treated with mixture of 0.3% collagenase and 0.2% alkaline protease-nagase at 31°C for 30 to 40 min. Thereafter, the slices were rinsed well with Ca2+-free EGTA solution and stored in well-oxygenated standard external solution. The cerebral frontal cortex, cerebellar Purkinje cell layer and Rexed's laminae VIII and IX in the spinal cord were then micropunched from the slices with a round tipped injection needle under the stereoscopic microscope (Nikon, SMZ-1) and transferred to a culture dish filled with well-oxygenated standard external solution. CTX, CPJ and SVH neurones in the pieces punched from the slices were dissociated mechanically with a fire-polished micro-Pasteur pipette. Neurones were used for experiments within 6 h after the cell dissociation.
Solutions
The composition of external and internal solutions was as follows. Standard external solution (in mM): NaCl 150, KCI 5, MgCl2 1, CaCI2, 2,N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 10 and glucuse 10. The pH was ajusted to 7.4 with tris(hydroxymethyl)aminomethane (Trisbase). Ca2"-free ethylenglycol-bis- (P-aminoethyl ether) subishi, VH-F32) after changing the signal to a digital mode, using a PCM processor (Nihon Kohden, PCM-SO1ESN).
Drugs
Enzymes used were: pronase (Calbiochem), thermolysin (Sigma), alkaline protease-nagase (Nagase biochemical) and collagenase (Yakuruto). All enzymes were dissolved just before use in standard external solution. Diazepam, 3-methyl-6-(3-trifluoromethyl-phenyl)-1 ,2,4-triazolo(4,3-b)pyridazine (CL218,872) and (± )-2-(4-chlorophenyl)-5,6-dihydro-
[l]benzothiepino [5,4-c] pyridazin-3(2H)-one 7-oxide (Y-23684) were synthesized by Yoshitomi Pharmaceutical Industries (Figure 1 ). They were first dissolved in dimethyl sulphoxide (DMSO) at 10-1 M, and then diluted to the final concentration in standard external solution. The maximum concentration of DMSO used was 0.2%, at which concentration it did not affect the GABA response.
Statistics
Data were calculated as mean ± standard error of the mean (s.e.mean) and significance was tested by Student's t test.
Results
GABA-induced IC/ in the CTX, CPJ and SVH neurones Figure 2 shows the GABA-induced Cl-current (Icl) in CTX (a) and SVH (b) neurones at a holding potential (VH) of -50 mV. Since the GABAA response recorded by the use of conventional whole-cell mode of patch-clamp technique decreases time-dependently, 5 mM MgATP was added to the internal solution to prevent the sensitivity-loss for the affinity of GABAA receptor (run-down) (Chen et al., 1990; Shirasaki et al., 1992) . When this was done, the GABA responses were maintained for more than 1 h and increased in a sigmoidal fashion with increase in the concentration of GABA. The responses rapidly activated and successively desensitized towards a steady-state level during continuous application of GABA, in both neurones and the CPJ neurone (raw data not shown). The desensitization was more accelerated with increase in the GABA concentration. The concentrationresponse relationships for GABA in these neurones are shown in Figure 3 . When the peak amplitudes of Ic, induced by GABA of various concentrations were normalized for the maximum values in respective concentration-response relationships, the concentration-response relationships in CPJ and SVH neurones were almost the same, but that in the CTX neurones shifted to a lower concentration-range. The (Yakushiji et al., 1989b) , neurones were pretreated with the agonist for 30 to 60s which gave the steady-state enhancement. Interestingly, diazepam enhanced the GABA response more strongly in SVH neurones than in CPJ neurones ( Figure 4 ). As shown in Figure 5( 
Where, I is the observed GABA-induced current in the presence of BZR agonist, Imax the maximum value of current, C the concentration of BZR agonist, KD the apparent dissociation constant, and n the Hill coefficient. At concentrations above 3 x 10-6 M, the augmentation ratio by diazepam decreased (Yakushiji et al., 1989b 23684, and 1.56 for CL218,872. There were no significant differences among the maximum augmentations of the GABA response by three full and partial agonists in dissociated CPJ neurones.
Effects of BZR agonists on CTX neurones
Because the GABA concentration-response relationship in CTX neurones lies in a lower concentration range than those in the other two regions (Figure 3 ), we chose 10-6 M GABA as a control. At this concentration, GABA induced a response of almost 10% of the maximum response. The facilitatory characteristics of partial agonists on the GABA response were similar to those in the other two preparations (SVH and CPJ). Threshold concentrations, KD values and maximum augmentation ratios of the GABA response were 10-8M, Figure Sc) . Threshold concentration (10-9 M), KD value (4.9 x 10-' M) and Hill coefficient (1.42) were similar to those in the CPJ and SVH neurones.
Concentration-response relationships for GABA in the presence of BZR agonists
As described above, the augmentation ratios of the GABA response by diazepam were significantly different in CPJ and SVH neurones. However, the augmentation ratios in CTX neurones which express both BZ1 and BZ2 lay between the values of CPJ and SVH neurones. Therefore, we examined how the BZR agonists change the GABA concentrationresponse relationships in CPJ and SVH neurones ( Figure 6 ). In both preparations, 3 x 10-M diazepam and 3 x 10-6 M Y-23684 were used, because they induced the maximum augmentation of GABA response in respective concentrationaugmentation relationships as shown in Figure 5 . In this condition, both diazepam and Y-23684 shifted the GABAconcentration-response curve to the left without changing the maximum response in both SVH and CPJ neurones. However, diazepam shifted the curve more strongly than Y-23684 in SVH neurones (Figure 6a ), whereas the effect of diazepam was the same as that of Y-23684 in CPJ neurones ( Figure  6b ). The maximum response and KD value of GABA response in SVH neurones were 2.22 and 1.3 x 10-M for control, 2.17 and 6.4 x 10-6 M in the presence of diazepam, and 2.18 and 8.5 x 10-6 M in the presence of Y-23684, respectively. The maximum response and KD value of the GABA response in CPJ neurones were 1.84 and 8.8 x 10-6 M for the control, 1.85 and 6.2 x 10-6 M in the presence of diazepam, and 1.88 and 6.3 x 10-6 M in the presence of Y-23684, respectively. Here, the maximum current amplitudes were shown relative to that induced by 10-M GABA alone, in individual preparations.
Discussion
GABA-induced Ich in CPJ and SVH neurones was very similar to those in acutely dissociated frog sensory (Yakushiji et al., 1989b) , rat hippocampal (Shirasaki et al., 1991) and nucleus tractus solitarii (NTS) neurones (Shirasaki et al., 1992) . However, the KD value in the concentration-response relationship for GABA in CTX neurones was lower than those in other preparations. Recent purification, molecular cloning, and re-expression studies have revealed that PI and y3 subunits of GABAA receptor make the recombinant receptor sensitive to GABA (Ymer et al., 1990; Knoflach et al., 1991) BZPs [Ml 10-6 10-5 Figure 5 Concentration-augmentation relationships of BZR agonists for GABA response at VH of -50 mV. The peak current amplitude induced by GABA with one BZR agonist as shown in Figure 4 was measured. All points were normalized for the peak amplitude induced by 10-6 M (in cortical (CTX) neurone), or 3 x 10-M (in both cerebellar Purkinje (CPJ) and spinal ventral horn (SVH) neurones) GABA alone. A continuous line was drawn, using Eqn (2). Each point is the average of 4 to 9 neurones with s.e.mean. Note that the concentation-augmentation relationships of CL218,872
(M) and Y-23684 (A) were very similar in these three different neurones; diazepam (e). affinity of recombinant GABAA receptor to a low concentration range . Moreover, recent in situ hybridization studies showed the restricted expression of the a5 subunit in the cerebral cortex, hippocampus and olfactory bulb . Therefore, the sensitivity of the GABAA receptor in CTX neurones is probably based on the presence of a5 subunit.
The main important findings in this study are as follows: (1) Partial and full agonists potentiated the GABA response equally in CPJ neurones (BZI predominant) . (2) The augmentation ratios of the GABAA response by two different partial agonists, Y-23684 and CL218,872, were the same, and there were no significant differences for the augmentation pattern among the preparations. (3) The threshold and KD values of diazepam action were the same in every preparation. For diazepam actions, it seems that the difference of augmentation ratio is not based on the varying numbers of BZR in each preparation, because (a) the maximum current amplitudes of the GABA response were close in both CPJ and SVH neurones, and (b) the Hill coefficients of the diazepam action were not much different in both preparations. Recently, Puia et al. (1991) reported that the augmentation ratio of the GABA response by diazepam depends on the variant of the ax subunit; that is, the efficacy of diazepam was two or three times greater for the c2p172 and 03p172 assemblages than for the a,P,12 assemblage. This finding is compatible with our present findings, because o, and X2 varients are predominant in CPJ and SVH neurones, respectively. The subtypes of BZR have been classified by the difference in sensitivity to CL218,872, in which the sensitivity was judged by receptor-binding studies at 0 to 4°C (Squires et al., 1979) . According to such an unphysiological binding study, Y-23684 is a non-selective agonist. Present functionally experiments also show the non-selective action of Y-23684 to BZR sensitivity. Judging from (a) this non-selectivity of Y-23684, (b) the result that the maximum augmentation ratios of two partial agonists were the same, and (c) the behavioural data that Y-23684 as well as CL218,872 has good anxioselectivity (Morimoto et al., 1990) , the possibility is considerable that BZR partial agonists and not BZ, selective agonists have anxioselectivity. In this case, it seems likely that diazepam acts as a partial agonist at the BZ, variant (CPJ neurone), but probably not for the reason at first suggested that the pharmacological and physiological properties of GABAA receptors, such as the sensitivity to GABA, maximum response, Hill coefficient and allosteric modulation, are different for different combinations of subunits. Moreover, KD values of three agonists used in the present study were close to those obtained from biochemical binding studies (Gee & Yamamura, 1982; Asano et al., 1983; Pritchett et al., 1989; ; Takehara, S. personal communication on Y-23684). This suggsts the absence of spare receptors for each receptor subtype. Therefore, the hypothesis described by Haefely (1987) is unlikely, because the presence of spare receptors and difference in the number of receptors are needed to explain the partial agonist action.
Previous classification of BZR subtype has been based on unphysiological binding properties, as mentioned above. Even considering those properties, the difference in affinity of BZR subtype is only close to 10 times. Moreover, the affinity for BZ, becomes temperature-dependent close to that for BZ2, and at 37°C the difference approaches 3 times (Gee & Yamamura, 1982; Pritchett et al., 1989) . Therefore, it may be unwise to classify the selectivity for some ligands such as Y-23684 only by the difference in affinity found in binding assays. In the present experiment, both Y-23684 and CL218,872 are almost 2 times more sensitive to BZ1-predominant CPJ neurones than to the other neurones in the study. However, we could not separate the selectivity by this point. Judging from the present results and anxioselectivity of Y-23684 and CL218,872, we propose here the new classification method based on the functional difference for the maximum enhancement of the GABA response by diazepam and CL218,872, that is, diazepam;zeCL218,872 for BZ,, and diazepam> CL218,872 for BZ2. As shown in Figure  4 , all BZR agonists shifted the concentration-response relationship for GABA to the left without changing the maximum current amplitude in each preparation. This indicates that at BZI and BZ2, three drugs augment the GABA response by increasing the affinity of the GABAA receptor for GABA. However, it is not clear at the present stage why the augmentation ratio of the GABA response by diazepam is smaller at BZ, than at BZ2, although it does depend on the GABAA receptor composition. To ascertain the validity of our proposition and to explain the different maximum augmentation ratio for diazepam action, further analysis using many other BZR agonists and single channel recordings is necessary.
In conclusion, it has been shown that heterogeneous expression of BZR in CNS neurones and its properties as obtained from re-expression study of GABAA receptors and in situ hybridization are indeed present in native mammalian CNS neurones. In addition, we proposed the possibility that the BZ, has an important role in the basal mechanism underlying the anxiety. In the present study, we used three distinct cell types. Each of them maintained well the physiological functions of receptors, ionic channels and intracellular signal transduction systems, as well as a different expression pattern for the GABA/BZP receptor subtypes. Thereby, our present findings offer useful data and provide one way to understand the basal mechanism of anxiety. Much experimentation in various CNS neurones contributing to anxiety is needed to support our hypothesis.
